Mammography specifically, and cancer screening in general, is often something of a muddle. We should acknowledge the trade-offs, work toward better screening methods, and in the interim -- muddle through.
The USPSTF has moved on from ambivalence about prostate cancer screening with the PSA test, and inveighed decisively against it -- a recommendation that is apt to stoke the flames of competing passions, and generate a whole lot of heat but altogether too little light.
Politicians are incapable of giving the public any bad news, and the insurance and health care industries care about profits. That leaves physicians and scientists to lead us through health care reform.